|
Volumn 6, Issue 6, 1998, Pages 488-489
|
Moving beyond acquisition cost reductionism: Editorial
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
ANTINEOPLASTIC AGENT;
NEW DRUG;
CANCER PAIN;
CANCER PATIENT;
COST CONTROL;
DRUG COST;
DRUG MONITORING;
EDITORIAL;
HEALTH CARE COST;
HEALTH INSURANCE;
HUMAN;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
DISEASE MANAGEMENT;
HUMANS;
NEOPLASMS;
UNITED STATES;
|
EID: 0031798245
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s005200050201 Document Type: Editorial |
Times cited : (1)
|
References (4)
|